Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Neoadjuvant Immunotherapy, Lung Cancer

Jamie Chaft

MD

🏢Memorial Sloan Kettering Cancer Center🌐USA

Associate Attending Physician, Thoracic Oncology

45
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Jamie Chaft leads clinical trials in early stage lung cancer at MSK, including LCMC3 neoadjuvant atezolizumab. Her work helped establish major pathologic response as a surrogate endpoint and informs patient selection for perioperative immunotherapy. She is a national leader in resectable NSCLC drug development.

Share:

🧪Research Fields 研究领域

early stage NSCLC
neoadjuvant atezolizumab LCMC3
pathologic response
adjuvant IO
clinical trial design

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Jamie Chaft 的研究动态

Follow Jamie Chaft's research updates

留下邮箱,当我们发布与 Jamie Chaft(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment